trial

Oculomotor and Spatial Cognition Deficits in Schizophrenia

NCTId NCT00931996
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 12 (actual)
Sponsored by University of Illinois at Chicago
Primary completion 2011-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
12 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2009-06
Primary completion
2011-11
Eligibility
ALL · 15 Years · 64 Years

Interventions & indications

Drugs
Antipsychotic

Sponsors

University of Illinois at ChicagoLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
John A Sweeney, PhDPrincipal Investigator

Sites

1 total
Chicago, United States

Facts & assertions

4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2011-11
Status
TERMINATED
relationships
The graph out of here
drug
Antipsychotic
drug
lead_sponsor
University of Illinois at Chicago
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
John A Sweeney, PhD
person